Literature DB >> 22004565

Needle-free jet injection of DNA and protein vaccine of the far-eastern subtype of tick-borne encephalitis virus induces protective immunity in mice.

Yuki Omori-Urabe1, Kentaro Yoshii, Ayae Ikawa-Yoshida, Hiroaki Kariwa, Ikuo Takashima.   

Abstract

Tick-borne encephalitis virus (TBEV) causes severe encephalitis in humans. It is endemic in one area of Japan; however no commercial vaccine is available in that country. In this Japan-based study, the efficacy of subviral particles (SPs) of TBEV administered by needle-free injector was evaluated as a vaccine candidate. Inoculation with SP-encoding DNA by needle-free injector induced neutralizing antibodies more efficiently than when administered by needle and syringe, and mice vaccinated with one dose by needle-free injector survived challenge with a lethal dose of TBEV. These results suggest that SP vaccines delivered by needle-free injector can protect against TBEV infection.
© 2011 The Societies and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22004565     DOI: 10.1111/j.1348-0421.2011.00389.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  3 in total

1.  A hantavirus pulmonary syndrome (HPS) DNA vaccine delivered using a spring-powered jet injector elicits a potent neutralizing antibody response in rabbits and nonhuman primates.

Authors:  Steve Kwilas; Jennifer M Kishimori; Matthew Josleyn; Kurt Jerke; John Ballantyne; Michael Royals; Jay W Hooper
Journal:  Curr Gene Ther       Date:  2014       Impact factor: 4.391

Review 2.  Tick-borne encephalitis in Japan, Republic of Korea and China.

Authors:  Kentaro Yoshii; Joon Young Song; Seong-Beom Park; Junfeng Yang; Heinz-Josef Schmitt
Journal:  Emerg Microbes Infect       Date:  2017-09-20       Impact factor: 7.163

3.  Exploring of primate models of tick-borne flaviviruses infection for evaluation of vaccines and drugs efficacy.

Authors:  Natalia S Pripuzova; Larissa V Gmyl; Lidiya Iu Romanova; Natalia V Tereshkina; Yulia V Rogova; Liubov L Terekhina; Liubov I Kozlovskaya; Mikhail F Vorovitch; Karina G Grishina; Andrey V Timofeev; Galina G Karganova
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.